We are live on
!
Find out more
AAP
Arax Advisory Partners Portfolio holdings
AUM
$3.54B
1-Year Est. Return
19.14%
This Fund
S&P 500
This Quarter
Est. Return
-1.19%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$1.56B
AUM Growth
-$29.8M
(-1.9%)
Cap. Flow
-$341K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
25.81%
Holding
3,122
New
704
Increased
853
Reduced
892
Closed
464
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantis Core Fixed Income ETF
AVIG
|
+$26.4M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$21.8M |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$19.4M |
| 4 |
Invesco Ultra Short Duration ETF
GSY
|
+$19.4M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$19.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional Core Fixed Income ETF
DFCF
|
+$25.2M |
| 2 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$24.8M |
| 3 |
iShares Russell 2000 Growth ETF
IWO
|
+$22M |
| 4 |
iShares S&P Mid-Cap 400 Value ETF
IJJ
|
+$20.9M |
| 5 |
iShares Russell 2000 Value ETF
IWN
|
+$20.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.41% |
| 2 | Financials | 3.2% |
| 3 | Healthcare | 2.44% |
| 4 | Consumer Discretionary | 2.3% |
| 5 | Industrials | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Stantec
STN
$8.39B
| $8.04K | ﹤0.01% |
97
+16
| +20% | +$1.28K |
|
|
FTHY
1627
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$497M
| $7.99K | ﹤0.01% |
+553
| New | +$8.04K |
|
1628
Tandem Diabetes Care
TNDM
$1.38B
| $7.99K | ﹤0.01% |
417
+400
| +2,353% | +$11.7K |
|
1629
Unity
U
$19.1B
| $7.97K | ﹤0.01% |
407
-608
| -60% | -$13.7K |
|
1630
iShares US Transportation ETF
IYT
$2.29B
| $7.94K | ﹤0.01% |
+124
| New | +$8.55K |
|
1631
Western Union
WU
$2.21B
| $7.88K | ﹤0.01% |
745
+156
| +26% | +$1.65K |
|
1632
Celestica
CLS
$35.9B
| $7.88K | ﹤0.01% |
+100
| New | +$10.6K |
|
1633
Axsome Therapeutics
AXSM
$10.9B
| $7.81K | ﹤0.01% |
67
+49
| +272% | +$5.58K |
|
1634
iShares MSCI Brazil ETF
EWZ
$9.07B
| $7.75K | ﹤0.01% |
300
| – | – |
|
1635
Church & Dwight Co
CHD
$24.5B
| $7.74K | ﹤0.01% |
70
-220
| -76% | -$23.5K |
|
1636
JPMorgan BetaBuilders Europe ETF
BBEU
$9.56B
| $7.72K | ﹤0.01% |
125
+1
| +0.8% | +$60 |
|
1637
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
| $7.69K | ﹤0.01% |
+162
| New | +$7.72K |
|
1638
MGE Energy Inc
MGEE
$3.03B
| $7.62K | ﹤0.01% |
82
+22
| +37% | +$2K |
|
1639
Oil States International
OIS
$498M
| $7.62K | ﹤0.01% |
1,479
-16,468
| -92% | -$86.5K |
|
1640
Rocket Lab Corp
RKLB
$50.2B
| $7.6K | ﹤0.01% |
+425
| New | +$10.2K |
|
1641
EPAM Systems
EPAM
$4.9B
| $7.6K | ﹤0.01% |
45
-22
| -33% | -$4.85K |
|
1642
Moelis & Co
MC
$4.99B
| $7.59K | ﹤0.01% |
130
-55
| -30% | -$3.88K |
|
1643
Kinross Gold
KGC
$32.6B
| $7.57K | ﹤0.01% |
+600
| New | +$6.73K |
|
1644
CTS Corp
CTS
$1.92B
| $7.56K | ﹤0.01% |
182
+7
| +4% | +$328 |
|
1645
T. Rowe Price Equity Income ETF
TEQI
$468M
| $7.54K | ﹤0.01% |
+180
| New | +$7.55K |
|
1646
Healthcare Realty
HR
$6.92B
| $7.52K | ﹤0.01% |
445
+59
| +15% | +$980 |
|
1647
Cullen/Frost Bankers
CFR
$10.1B
| $7.51K | ﹤0.01% |
60
-103
| -63% | -$13.8K |
|
|
NXG
1648
NXG NextGen Infrastructure Income Fund
NXG
$336M
| $7.48K | ﹤0.01% |
+159
| New | +$7.66K |
|
1649
Stepan Co
SCL
$1.46B
| $7.43K | ﹤0.01% |
+135
| New | +$8.24K |
|
1650
Recursion Pharmaceuticals
RXRX
$1.73B
| $7.41K | ﹤0.01% |
1,400
+1,120
| +400% | +$8.16K |
|
Similar funds
TYCC
TH
BCP
WWA
VPC
BPS
TCM
DILIC
Arax Advisory Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Arax Advisory Partners held 3,122 positions worth $1.56B, down 1.9% from $1.59B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Arax Advisory Partners's Q1 2025 filing shows 704 new, 853 increased, 892 reduced and 464 closed positions. Its largest new stake was Avantis Core Fixed Income ETF: 645,396 shares worth $26.7M. The largest sale was Dimensional Core Fixed Income ETF, an estimated $25.2M.
By sector, the portfolio is most concentrated in Technology at 5.4% of assets, down from 5.9% a quarter earlier, followed by Financials and Healthcare.
- Arax Advisory Partners's largest Q1 2025 buy was Avantis Core Fixed Income ETF: 645,396 shares worth $26.7M.
- Arax Advisory Partners added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, an estimated $21.8M increase.
- Arax Advisory Partners's biggest Q1 2025 reduction was Dimensional Core Fixed Income ETF, cutting an estimated $25.2M.
- Arax Advisory Partners fully exited Berkshire Hathaway Class B in Q1 2025, selling an estimated $1.03M.
- Arax Advisory Partners's ten largest holdings make up 26% of its $1.56B portfolio in Q1 2025.
- Arax Advisory Partners opened 704 new positions and closed 464 in Q1 2025.
- Arax Advisory Partners's portfolio value fell 1.9% quarter-over-quarter to $1.56B.
Based on Arax Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.